Use of the Wearable Cardioverter Defibrillator in High-Risk Cardiac Patients
Author(s) -
Valentina Kutyifa,
Arthur J. Moss,
Helmut Klein,
Yitschak Biton,
Scott McNitt,
Bonnie MacKecknie,
Wojciech Zaręba,
Ilan Goldenberg
Publication year - 2015
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.115.015677
Subject(s) - medicine , ejection fraction , implantable cardioverter defibrillator , cardiology , ischemic cardiomyopathy , defibrillation , ventricular tachycardia , cardiomyopathy , sudden cardiac death , heart failure
Prospective data on the safety and efficacy of the wearable cardioverter defibrillator (WCD) in a real-world setting are lacking. The Prospective Registry of Patients Using the Wearable Defibrillator (WEARIT-II) Registry was designed to provide real-world data on the WCD as a strategy during a period of risk stratification.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom